Search
Searching Content from Canada indexed under Patent ordered by Published Date Descending.
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next
 
Title
Country
Organisation
Author
Date
1
Après un second coup d'œil, la CAF confirme le rejet de demande en contrefaçon dans un litige portant sur des dispositifs médicaux ophtalmiques
Dans TearLab Corporation c. I-MED Pharma Inc, 2019 FCA 179, la Cour d'Appel Fédérale (CAF) a confirmé le rejet de l'action en contrefaçon de brevet de TearLab contre I-MED.
Canada
19 Jul 2019
2
Canada's New Patent Rules Are Final
The Government of Canada has published finalized amendments to the Patent Rules (final rules) in the Canada Gazette, Part II on July 10
Canada
19 Jul 2019
3
Judicial Exclusions To Patent Eligibility In The U.S. – The Beginning Of The End?
The United States is often the largest target market for Canadian innovators, but exceptions to patentability extended by U.S. courts in recent years have made it difficult for innovators to obtain
Canada
18 Jul 2019
4
Publication Of The Finalized Patent Rules, And Announcement Of Coming-Into-Force Date
The Government of Canada published the new Patent Rules in the Canada Gazette Part II today (July 10, 2019). This publication of the finalized Rules
Canada
18 Jul 2019
5
Federal Court Of Appeal: Obviousness Is An "Inherently Factual" Inquiry
Recently, the Federal Court of Appeal published its decision in Packers Plus Energy Services Inc. v. Essential Energy Services Ltd.,[1] in which the appellant
Canada
18 Jul 2019
6
Pre-Amended PMNOC Regulations: Court Decisions On The Merits (Polymorph, Salt, Formulation Patents)
There have been two Patented Medicines (Notice of Compliance) Regulations (PMNOC Regulations) decisions on the merits so far in 2019 and a pair of appeal decisions
Canada
16 Jul 2019
7
PMPRB News: Amendments Still Not Released; Alexion/SOLIRIS, Galderma/DIFFERIN Decisions
While originally proposed to come into force on January 1, 2019, sweeping amendments to the Patented Medicines Regulations governing pricing criteria were still not released as of June 30
Canada
16 Jul 2019
8
A Tearful Conundrum: FCA Affirms Dismissal Of Infringement Claim In Patent Suit Regarding Ophthalmic Medical Devices
In TearLab Corporation v I-MED Pharma Inc., the Federal Court of Appeal (FCA) upheld the dismissal of TearLab's patent infringement action against I-MED.
Canada
16 Jul 2019
9
Protecting IP In China: The Utility Model Opportunity
With a population of 1.3 billion, China is the world's second-largest economy and represents an exciting developing global market
Canada
15 Jul 2019
10
Third Party Rights Coming To Canada To Join New Prior User Rights
Patent practice in Canada is changing1 as the government aims to ratify its commitment to the Patent Law Treaty. As part of these changes, amendments to the Patent Act and upcoming Patent Rules
Canada
15 Jul 2019
11
Significant Changes Are On The Horizon For Canadian Patent Prosecution
On December 16, 2014, Bill C-43 received Royal Assent. The legislation included long-awaited amendments to Canada's Patent Act to implement obligations under the Patent Law Treaty (PLT)
Canada
15 Jul 2019
12
Interim Injunction Granted
A judge of the Federal Court recently granted an interim injunction in a case involving patent infringement. This is very unusual.
Canada
15 Jul 2019
13
Why The C-Suite And IP Team Should Talk
In markets being changed by disruptive technology, intellectual property can be a CEO's best friend. But seeing IP as 'legal' not commercial misses the bigger picture.
Canada
12 Jul 2019
14
Protecting Technology And IP In The Age Of AI And Collaborative Technology Development
Technology evolves at an ever faster pace. As it evolves, the underlying engineering approaches to technology development and innovation also change.
Canada
12 Jul 2019
15
Increasing Use Of IP For Blockchain Inventions
While there is no agreed upon definition of blockchain, this technology is often associated with an append-only, tamper-resistant, distributed ledger of peer-to-peer transactions maintained by a decentralized network of participants.
Canada
12 Jul 2019
16
Federal Court Of Appeal Provides Important Guidance For Determining Jurisdiction Of The PMPRB
On June 28, 2019, in the Federal Court of Appeal's decision in Attorney General of Canada v Galderma Canada Inc., 2019 FCA 196, the Court confirmed that the Patented Medicines Price Review Board acted unreasonably.
Canada
12 Jul 2019
17
Detailed Overview Of Deadlines And Requirements Under The New Canadian Patent Rules Coming Into Force On October 30, 2019
In this article, we provide a detailed analysis of revised requirements under the new Rules, together with recommendations for best practices.
Canada
12 Jul 2019
18
Federal Court Of Appeal Agrees That The PMPRB Incorrectly Applied The Patent-Pertaining Analysis
The Federal Court of Appeal has provided new guidance on the proper approach to the "patent pertaining" analysis used by the Patented Medicine Prices Review Board, including on the identification of the medicine ...
Canada
11 Jul 2019
19
Federal Court Upholds PMPRB's Pricing Decision Regarding Alexion's SOLIRIS
On June 12, 2019, Justice Gleeson dismissed Alexion's application for judicial review of a Panel of the Patented Medicines Price Review Board (PMPRB)'s (i) decision
Canada
10 Jul 2019
20
Doing Business In Canada 2019 - Protection Of Intellectual Property
The protection of intellectual property is primarily a federal responsibility and is the subject of four principal federal statutes: Patent Act, Trade-marks Act, Copyright Act, and Industrial Design Act.
Canada
9 Jul 2019
Links to Result pages
 
1 2 3 4 5 6 7 8 9 10 11 . . .  
>>Next